CSPC Pharmaceutical Group Limited (003020.SZ): The application for registration and listing of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets has been accepted.

Zhtng Cijng APP News, Livzon Pharmaceutical Group Inc. (003020.SZ) announced that recently, the company has received the "Acceptance Notification" for the application for the registration and listing of three types of Dapagliflozin and Metformin Hydrochloride extended-release tablets (I), (II) and (III) issued by the National Medical Products Administration.